Quarterly report pursuant to Section 13 or 15(d)

Acquisition (Details Narrative)

v3.24.2.u1
Acquisition (Details Narrative) - USD ($)
6 Months Ended
May 15, 2024
Dec. 01, 2023
Mar. 01, 2023
Jun. 30, 2024
Jun. 30, 2023
Jan. 06, 2023
Business Acquisition [Line Items]            
Payment to acquire business     $ 500,000 $ 400,000  
C.G. Laboratories Inc. [Member]            
Business Acquisition [Line Items]            
Minority percentage     50.00%      
Moiety [Member]            
Business Acquisition [Line Items]            
Minority percentage           50.00%
Silly George Acquisition [Member]            
Business Acquisition [Line Items]            
Cash payment for acquire assets $ 400,000          
Business acquisition, number of value issued $ 200,000          
Business acquisition, number of shares issued 89,892          
Business acquisition, net profit percentage 20.00%          
Net tangible assets acquired $ 600,000          
Kenkoderm Acquisition [Member]            
Business Acquisition [Line Items]            
Cash payment for acquire assets   $ 546,500        
Payments to acquire businesses, cash earn-out   136,625        
Net tangible assets acquired   $ 169,000        
Joint Venture [Member]            
Business Acquisition [Line Items]            
Acquisition percentage     50.00%      
CG Labs [Member]            
Business Acquisition [Line Items]            
Net tangible assets acquired     $ 1,000,000      
Acquisition percentage     50.00%      
Enigma Health Joint Venture [Member]            
Business Acquisition [Line Items]            
Acquisition percentage           50.00%
Joint venture formation capital contribution       20,000    
Minority interest       $ 37,000